Skip to search formSkip to main contentSkip to account menu

lipoplatin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cisplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A phase II trial of lipoplatin and gemcitabine in patients with NSCLC previously treated with platinum-based chemotherapy
Background: A phase I trial 1 of lipoplatin and gemcitabine (1000 mg/m 2 D 1,8) in pretreated NSCLC patients has established the… 
2016
2016
Preliminary results of a phase II study of liposomal cisplatin-vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer (MBC)
1068 Background: The frequent use of anthracyclines and taxanes in breast cancer's adjuvant setting has lead to drug resistance… 
2014
2014
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMACIA DISCIPLINA DE TRABALHO DE CONCLUSAO DE CURSO DEVELOPMENT OF A CELL-TARGETED LIPOSOME FORMULATION FOR SMALL CELL LUNG CANCER
Lung cancer is one of the most common cancers with small cell lung cancer (SCLC) representing 18% of the total lung cancer… 
2011
2011
Lipoplatin tm: a less neurotoxic formulation of cisplatin
2009
2009
Is Lipoplatinum Monotherapy an Active Alternative in Second Line Treatment of Metastatic Non–Small Cell Lung Cancer? A Phase II Trial
Lipoplatin is a liposome encapsulated form of cisplatin. Phase I studies on Lipoplatin showed an excellent toxicity profile of… 
2008
2008
Liposomally-encapsulated cisplatin (Lipoplatin) plus gemcitabine in NSCLC: Preliminary results of a phase II trial and its antiangiogenesis potential
19024 Background: Liposomally-encapsulated cisplatin (Lipoplatin) nanoparticles evade immune surveillance, target tumor cells in…